Lexeo Therapeutics Inc banner

Intrinsic Value

Not Available for LXEO

There is not enough data to reliably calculate the intrinsic value for Lexeo Therapeutics Inc.

Do our valuations actually work? See backtest results .

Alternatives to LXEO

Fundamental Analysis

What Lexeo Therapeutics Does

Biotechnology Health Care

Lexeo Therapeutics is a biotechnology company that develops gene therapies for serious diseases caused by faulty genes. Its main work is to design and test one-time treatments that use viral vectors to deliver working copies of genes into a patient’s cells. The company focuses on diseases in areas such as the heart and the nervous system, where there are often few good treatment options.

Headquarters
United States of America US
Employees
59
IPO date
Nov 3, 2023
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

Lexeo Therapeutics insiders are selling within their usual range

Insider trading · Last trade on Aug 18, 2026

Sold $697.2k 4 insiders
Bought $0 Nobody bought
Trades by date
Open insider trading

Continue LXEO Research

Decided on Lexeo Therapeutics? Get an email when LXEO reaches the price you’d buy at. Free with an account.

Back to Top